Featured Story | | | Thursday, September 7, 2017 As CAR-T and T-cell therapies continue to make headlines, GlaxoSmithKline has taken up the option to work on Adaptimmune’s T-cell therapy. |
|
|
Top Stories Thursday, September 7, 2017 Alnylam has suspended dosing in trials of RNAi drug fitusiran after a patient with hemophilia A died in one of the studies. The biotech is now developing a strategy to mitigate the risk of more patients suffering fatal blood clots before resuming the trials. Thursday, September 7, 2017 As part of a major series of global cuts across its divisions, Eli Lilly is putting two research centers on the chopping block. Thursday, September 7, 2017 A first-in-class therapy developed by AstraZeneca and Amgen looks like a strong treatment candidate for severe uncontrolled asthma, according to a respiratory specialist. Thursday, September 7, 2017 After getting off a $102 million series A, Gritstone Oncology has followed up with an impressive $92.7 million second round. Thursday, September 7, 2017 Verona Pharma has released results showing that adding its RPL554 to Boehringer Ingelheim’s Spiriva improves lung function in chronic obstructive pulmonary disease (COPD) patients. Data from the small phase 2a trial suggest Verona’s PDE3/PDE4 inhibitor may complement long-acting muscarinic antagonist bronchodilators such as Spiriva. | This week's sponsor is FierceBiotech. | |  | FierceBiotech Executive Summit- London
Join FierceBiotech for our third annual Executive Summit in London. We'll gather the experts together to discuss innovation around R&D in the UK and look ahead to what's in store for 2018 with leaders in the field discussing trends in the industry. |
Resources Presented By: Decision Resources Group Uncover the true power of patient-centric data with this valuable industry resource. Click here to discover more Sponsored by: Ashfield Healthcare Join this webinar to learn how to design, deliver, and measure a successful patient support program. Presented by Nareda Mills, Ashfield's SVP of Patient Services in the US, you’ll discover how to improve adherence and improve patient outcomes using 5 key methods. Presented By: PRA Health Sciences Children participating in pediatric clinical trials are included in the contraceptive requirements applied to women of child-bearing potential, creating significant challenges for sponsors, parents, investigators and study staff. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. | 
